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The dissertation thesis deals with the issue of matrix effects in analysis using 
liquid chromatography coupled to mass spectrometry (LC-MS). LC-MS represents a 
well-established, widely used, and powerful tool in the field of qualitative and 
quantitative analysis of a wide range of different compounds. Despite all the 
advantages offered by LC-MS such as sensitivity, selectivity, and robustness, it 
suffers from a major drawback represented by matrix effects. This undesirable 
phenomenon affects important parameters of LC-MS method such as accuracy, 
precision, linearity, limit of detection, and limit of quantification. Therefore, an 
evaluation of these effects should be involved in validation of every single LC-MS 
method and their source should be eliminated. The assessment is generally 
performed by qualitative and quantitative approaches such as post-extraction 
addition, post-column infusion, and comparison of slopes of calibration curves.   
The matrix effects can be reduced or fully eliminated by an intervention in each 
step of the whole LC-MS analysis. Sample preparation procedures may remove the 
origin of the matrix effects even prior the LC-MS analysis. Efficient chromatographic 
method allows to separate the interferences from the analyte of the interest before 
reaching ion source of the mass spectrometer which represents the primary place 
of their formation. The matrix effects can be also prevented by changing ion source 
parameters. Different calibration approaches may fully compensate the already 
exhibited matrix effects. 
Experimental part of the dissertation thesis focuses on development of LC-MS 
and SFC-MS methods for determination of clinically relevant compounds contained 
in complex matrices and the evaluation and removing of the matrix effects. The 
target analytes were represented by antioxidant catechins, neurotoxic amino acid 
β-N-methylamino-L-alanine, cholesterol-lowering statins, and vitamins. 
